- Parameter NEDA-3 from the point of view of current treatment of multiple sclerosis2023 | Faculty of Medicine in Hradec Králové
- Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis2021 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?2017 | First Faculty of Medicine
- Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: A longitudinal, retrospective study2020 | First Faculty of Medicine
- Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis2021 | First Faculty of Medicine
- Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study A Randomized Clinical Trial2021 | First Faculty of Medicine
